Document is current
Any future updates will be listed below
-
Authors
Davtyan, Hayk
Naguib, Sarah
Voskobiynyk, Yuliya
Chadarevian, Jean Paul
Capocchi, Joia K.
Giacchino, Jeannie L.
Eskandari-Sedighi, Ghazaleh
DeNittis, Vivianna
Ford, Jeremy B.
Agababian, Ani
Nguyen, Jasmine
Chadarevian, Alina L.
Sutherland, Madison S.
Shabestari, Sepideh Kiani
Tran, Kayla
Holt, Bret
Nana, Alissa L.
Zhang, Jiasheng
Spina, Salvatore
Wong, Man Ying
Grinberg, Lea T.
Seeley, William W.
Huang, Eric
Clelland, Claire D.
Gong, Shiaoching
Fan, Li
Paz, Jeanne T.
Blurton-Jones, Mathew
Gan, Li
-
Funding
Funding for this research was provided by:
National Institute on Aging
Alzheimer's Disease Research Center
NOMIS Gladstone Fellowship
Larry L. Hillblom Foundation
Alzheimer Society
BrightFocus Foundation
California Institute for Regenerative Medicine
Cure Alzheimer's Fund
Rainwater Charitable Foundation
- License Information
-
More Information
Article History
Received: 14 January 2026
Accepted: 9 July 2026
First Online: 16 July 2026
Declarations
Competing interests: M.B.J. is a co-founder and consultant for Savanna Biotherapeutics (formerly NovoGlia Inc.). L.G is founder and equity holder of Aeton Therapeutics, co-founder and equity holder of NeuroVanda Therapeutics; scientific advisor of Arvinas, NeuroLamda, and consultant for Retro Biosciences.
